{"url_path":"/sec/kblb/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1413119/0001493152-26-023130-index.html","accession_number":"0001493152-26-023130","cik":"0001413119","ticker":"KBLB","issuer_name":"Kraig Biocraft Laboratories, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1413119/0001493152-26-023130-index.html","primary_entity_key":"0001413119","primary_entity_name":"Kraig Biocraft Laboratories, Inc."},"word_count":84,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFrom\ntime to time, the Company may become a party to litigation or other legal proceedings that it considers to be a part of the ordinary\ncourse of its business. To the best of our knowledge, the Company is not currently involved in any legal proceedings that could reasonably\nbe expected to have a material adverse effect on our business, prospects, financial condition, or results of operations; however, the\nCompany may become involved in material legal proceedings in the future."}